Postoperative Rotator Cuff Rehabilitation: Functional, Pain and Sleep Quality
Launched by LAURA CASTILLO VEJAR · Aug 18, 2025
Trial Information
Current as of September 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how people recover after surgery for rotator cuff injuries, which affect the shoulder and can cause pain and trouble moving. After surgery, patients usually keep their shoulder still for 4 to 6 weeks before starting physical therapy, which can last several months. However, there isn’t a clear plan yet on the best way to do this therapy or what to expect during recovery. This study aims to better understand how physical therapy affects pain, shoulder function, and sleep quality after surgery.
The trial is open to people over 50 who have had arthroscopic surgery (a minimally invasive procedure) to repair one or more rotator cuff tendons. Participants will need to agree to join the study and attend physical therapy sessions for up to 12 weeks after surgery. People with certain complications like stiffness in the shoulder, nerve problems in the neck, sleep disorders, or difficulty following instructions won’t be able to join. If you take part, you can expect to work closely with the therapy team during your recovery to help improve your shoulder movement, reduce pain, and support better sleep. This study hopes to find clearer guidance to help future patients heal more effectively after rotator cuff surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People over 50 years of age
- • People have undergone arthroscopic rotator cuff of one or more tendons.
- • Patients must sign informed consent and undergo physical therapy center (up to week 12 postoperatively).
- Exclusion Criteria:
- • Patients who develop postoperative stiffness or adhesive capsulitis during the rehabilitation process.
- • Patients with symptoms of cervical radiculopathy or previously diagnosed sleep disorders.
- • Patients with neurological or cognitive disorders who have difficulty following instructions
About Laura Castillo Vejar
Laura Castillo Vejar is a clinical trial sponsor dedicated to advancing medical research through the design and oversight of innovative clinical studies. Committed to upholding the highest standards of scientific rigor and ethical conduct, she focuses on contributing to the development of safe and effective therapeutic interventions aimed at improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Laura LA Castillo-Vejar
Principal Investigator
TRIMEDKINE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported